BTIG Maintains Sell on Ginkgo Bioworks Holdings, Lowers Price Target to $0.2
Portfolio Pulse from Benzinga Newsdesk
BTIG analyst Mark Massaro maintains a Sell rating on Ginkgo Bioworks Holdings (NYSE:DNA) and lowers the price target from $0.5 to $0.2.
June 26, 2024 | 12:44 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
BTIG analyst Mark Massaro maintains a Sell rating on Ginkgo Bioworks Holdings and lowers the price target from $0.5 to $0.2.
The lowered price target and maintained Sell rating by BTIG analyst Mark Massaro indicate a negative outlook for Ginkgo Bioworks Holdings. This is likely to result in a short-term decline in the stock price as investors react to the bearish sentiment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100